779 related articles for article (PubMed ID: 9043821)
1. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
[TBL] [Abstract][Full Text] [Related]
2. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
Obrosova IG; Stevens MJ
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
[TBL] [Abstract][Full Text] [Related]
3. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-alpha-lipoic acid.
Obrosova I; Cao X; Greene DA; Stevens MJ
Diabetologia; 1998 Dec; 41(12):1442-50. PubMed ID: 9867211
[TBL] [Abstract][Full Text] [Related]
4. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
Beyer-Mears A; Diecke FP; Mistry K; Ellison C; Cruz E
Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
7. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
Malamas MS; Hohman TC; Millen J
J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
[TBL] [Abstract][Full Text] [Related]
8. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
Gonzalez AM; Sochor M; Hothersall JS; McLean P
Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.
Lee SM; Schade SZ; Doughty CC
Biochim Biophys Acta; 1985 Sep; 841(3):247-53. PubMed ID: 3927985
[TBL] [Abstract][Full Text] [Related]
10. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy.
Van den Enden MK; Nyengaard JR; Ostrow E; Burgan JH; Williamson JR
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1675-85. PubMed ID: 7601647
[TBL] [Abstract][Full Text] [Related]
11. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
13. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats.
Winkler BS; Arnold MJ; Brassell MA; Sliter DR
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):62-71. PubMed ID: 9008631
[TBL] [Abstract][Full Text] [Related]
14. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats.
Unakar NJ; Tsui JY; Johnson MJ
J Ocul Pharmacol; 1992; 8(3):199-212. PubMed ID: 1453083
[TBL] [Abstract][Full Text] [Related]
15. Glutathione depletion in the lens of galactosemic and diabetic rats.
Lou MF; Dickerson JE; Garadi R; York BM
Exp Eye Res; 1988 Apr; 46(4):517-30. PubMed ID: 3133235
[TBL] [Abstract][Full Text] [Related]
16. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport.
Cammarata PR; Chen HQ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733
[TBL] [Abstract][Full Text] [Related]
17. A new approach against sugar cataract through aldose reductase inhibitors.
Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
[TBL] [Abstract][Full Text] [Related]
18. Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.
Forster HG; ter Wee PM; Hohman TC; Epstein M
Diabetologia; 1996 Aug; 39(8):907-14. PubMed ID: 8858212
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+.
Tilton RG; Baier LD; Harlow JE; Smith SR; Ostrow E; Williamson JR
Kidney Int; 1992 Apr; 41(4):778-88. PubMed ID: 1513100
[TBL] [Abstract][Full Text] [Related]
20. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
